A No-Nonsense Approach to Inherited Disease
A new generation of non-viral vectors can help treat more genetic disorders while making gene therapy easier and safer – and new treatment modalities promise to entirely change the management of inherited eye disease
Mariya Moosajee | | Longer Read
At a Glance
- Gene therapy for inherited eye diseases of the eye is conceptually attractive, but has drawbacks relating to vector characteristics and health economics
- Now, innovative vectors both circumvent the transgene silencing issue associated with legacy non-viral vectors and avoid the capacity limitations, immunogenicity and insertional mutagenesis potential of viral vectors
- At the same time, new classes of therapeutics – including nonsense suppressors – promise the ability to ameliorate multiple inherited diseases with a single drug
- Together, these advances are likely to provide patients with new and effective options and to transform both the management of genetic disease and the economics of the gene therapy sector.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine